---
source_pdf: "https://drive.google.com/file/d/1RYBMmGgcYj6gUicQNgznDWVb2qXpaR8S/view"
drive_folder: "Research"
type: research

ingested: 2025-12-27
original_filename: "DocNexus Deck2024_Investment.pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1RYBMmGgcYj6gUicQNgznDWVb2qXpaR8S/view)

## Slide 1: Cover Page
# docnexus
A next-generation data platform designed to bring life-saving products to market

**Visible UI elements and text snippets:**
*   doc nexus logo
*   Login button
*   KOL Search
*   Publications
*   News
*   Decision Points
*   Supercharge your Medical Affairs Strategy.
*   Dashboard views with charts, maps, and network graphs.
*   $82,914.67
*   $132,914.67
*   5209 K

## Slide 2: WHY DOCNEXUS?
DocNexus can help life science organizations improve HCP/KOL Engagement by 45%, Increase Market Share, and Generate Medical & Commercial Insights that save millions a year

### DOCNEXUS' MISSION
Empowering the next-generation of life science organizations to bring medical device and pharmaceutical products to market faster by searching a global ecosystem of millions of HCPs, HCOs, Life Science Firms, & Insights

*   **DocNexus Search**
    Utilize DocNexus's AI-powered knowledge graphs of millions of HCP, HCOs, and Manufacturers to work smarter and move faster.
*   **Therapeutic Areas**
    Our next-generation command center for life sciences provides teams with all of the information they need to make informed decisions and new connections on one comprehensive, customizable dashboard.
*   **Who We Help**
    DocNexus supports small, medium, and enterprise organizations. We are focused on Medical Device, Biotech, and Pharmaceutical firms. We support Medical Affairs, Commercial teams, and Researchers as they bring products to market.

| Metric         | Value |
| :------------- | :---- |
| Publications   | 33.4M |
| HCPs           | 7M+   |
| HCOs           | 30K+  |
| Manufacturers  | 10K+  |
| Clinical Trials | 400K+ |

## Slide 3: OPTIMIZING WORKFLOW
DocNexus supports and streamlines stakeholder engagement workflow

**HCP Engagement Cycle:**
*   KOL Identification
*   Insight Management
*   HCP Analytics

**CRM/Insights Cycle:**
*   Claims Data
*   NLP Engine
*   CRM /Sales Data

---
With access to a real-time, comprehensive database of HCPs, including their affiliations, publications, and payments, DocNexus enables targeted and personalized KOL identification and outreach.
---
DocNexus supports CRM and sales efforts by providing valuable insights to enhance customer interactions. With comprehensive claims and sales data, along with our NLP engine, DocNexus fosters a cohesive and informed CRM strategy.
---

## Slide 4: THE WORKFLOW
DocNexus significantly improves today's increasingly complex Medical Affairs & Commercial workflow

### BEFORE docnexus
*Bridging Medical Affairs with AI*
*   **Central Figure:** A stylized doctor figure, representing a complex, disconnected workflow.
*   **Connected Elements (via dashed lines, indicating manual or fragmented connection):**
    *   PubMed
    *   NIH U.S. National Library of Medicine ClinicalTrials.gov
    *   LinkedIn
    *   SharePoint
    *   Internal Data
    *   OPEN PAYMENTS™
    *   Google Scholar
    *   CRM (with segments for Marketing, Support, Sales, Feedback, Administration)

### AFTER docnexus
*Bridging Medical Affairs with AI*
*   **Central Figure:** doc nexus logo, representing a unified platform.
*   **Connected Elements (via solid lines, radiating from DocNexus, indicating integration):**
    *   PubMed
    *   NIH U.S. National Library of Medicine ClinicalTrials.gov
    *   LinkedIn
    *   SharePoint
    *   Internal Data
    *   OPEN PAYMENTS™
    *   Google Scholar
    *   CRM (with segments for Marketing, Support, Sales, Feedback, Administration)

## Slide 5: THE SOLUTION
DocNexus helps bridge the gap between Medical & Commercial and KOLs by serving as an end-to-end platform

A next-generation data platform designed to bring life-saving products to market

**Workflow Cycle (Circular Diagram):**
*   Discover
*   Identify
*   Engage
*   Manage

**Detailed Descriptions:**
*   **Discover:** Search DocNexus' platform for Key Opinion Leaders (KOLs)
*   **Identify:** Utilize DocNexus' AI Powered knowledge graphs to identify similar KOLs (Based on Payments, Publications, Clinical Trials, Social Media)
*   **Engage:** Share knowledge across your organization, use our real-time feed to keep up to date on your therapeutic area
*   **Manage:** Process internal data that lives within customer relationship management (CRM) and sales platforms and utilize DocNexus' NLP engine & algorithms to save teams at least 25-40 hours

## Slide 6: AI-Powered Knowledge Graphs of HCPs
**Image Description:** A complex network graph showing interconnected nodes.
*   **Central Node:** Vaccine Concept (orange)
*   **Clusters:** Multiple clusters of red nodes (representing HCPs) connected to the Vaccine Concept.
*   **Specific Connections:**
    *   "Specific Vaccines (Prevnar, Gardasil, etc)" connected to some HCPs/clusters.
    *   "KOLs" identified as specific blue nodes within clusters.
    *   "KOL Medical Specialties" connected to KOLs.
*   **Overall:** Illustrates millions of HCPs linked through various biomedical concepts.

Search Millions of HCPs, HCOs, Life Science Orgs, Products, Conditions, and Biomedical Concepts

## Slide 7: DOCNEXUS KNOWLEDGE GRAPHS & HCP SEARCH
DocNexus helps bridge the gap between Medical Affairs & Commercial and KOLs by serving as an end-to-end platform

**Main Knowledge Graph (similar to Slide 6):**
*   **Central Node:** Vaccine Concept
*   **Connected Elements:** Specific Vaccines (Prevnar, Gardasil, etc), KOLs, KOL Medical Specialties.

**"Select Your Model" Panel:**
*   **Report Summary:** Summarize Medical Affairs Reports and identify relevant information based on your staff, KOL, interviews, and other relevant data
*   **Keyword Extraction:** Use TF-IDF to determine named entities, KOLs, SNOMed Terms, Medical diseases, treatments, conferences, healthcare providers
*   **Answer Questions:** Robust pipeline to answer any questions within your internal documentation. Have a question, instantly search and find an answer
*   **Select Your Input Source:** Upload File / Paste Text (Drag and drop or browse your files (*.txt only))
*   Submit For Analysis

**"Dr. Deepak Bhatt" Dashboard Screenshots (multiple panels):**

**Panel 1: Overview**
*   **Dr. Deepak Bhatt**
*   Internal Medicine, Cardiovascular Disease
*   (610) 485-25493
*   Piedmont Hospital Valve Center
*   Boston, MA
*   **Clinical trial ranking:** 89% (Expert)
*   **Socials:** 22.3 K Followers, 14.2 K Total Tweets
*   **Keywords:** (Graph with Keywords like Cardiovascular, Heart Failure, etc.)
*   **Clinical trial overview:** (Line graph)
*   **Total trials conducted:** (Bar chart for A Investigators, B Investigators, etc.)
*   **Condition:** (Breakdown by Heart Failure, Cardiovascular)
*   **Drugs:** (List of drugs, e.g., Eliquis)
*   **Journals/News:** (Example: Cell, Nature)

**Panel 2: Payments Data**
*   **Dr. Deepak Bhatt** | Internal Medicine, Cardiovascular Disease
*   General payments across all years (Line graph)
*   Top manufacturers payment over time (Line graph)
*   Breakdown of payments by company (Pie chart, $289K total payments)
*   **Manufacturer payment summary:**
    | Company name                     | Payment     |
    | :------------------------------- | :---------- |
    | AstraZeneca Pharmaceuticals LP  | $751,228.68 |
    | Merck Sharp & Dohme Corporation  | $359,334.62 |
    | Incyte Corporation               | $153,423.75 |
    | AstraZeneca UK Limited          | $153,228.68 |
    | Others                           | $64,002.00  |

**Panel 3: Social/News Analysis**
*   **Dr. Deepak Bhatt**
*   Word Cloud of Tweets (e.g., lifestyle, Hypertension, health problems)
*   Recent mentions/news (e.g., Bristol Myers Squibb elects Deepak L. Bhatt, MD, MPH to Board of Directors)
*   Social network graph showing connections.

## Slide 8: THERAPEUTIC AREAS
DocNexus can help identify HCPs/KOLs and trends across therapeutic areas based on real-time information

**Filtering Options (Left Panel):**
*   **Locations:** City, State
*   **HCP:** Specialty, FirstName, LastName
*   **HCO Affiliation:** HCO Affiliation
*   **Ranking:** Publication, Clinical
*   **Advanced:** Product, Hyperthyroidism, Life Science Firm
*   SEARCH, CLEAR buttons

**Map View (Center):**
*   Map of North America, showing clusters of HCO-Affiliated HCPs and HCPs.
*   Specific numbers indicate density in various regions (e.g., 21 in Washington, 35 in Chicago).
*   Keyboard shortcuts Map data ©2023 Google, INEGI Terms of Use

**Showing Top 500 HCPs Table (Bottom Panel):**

| # | HCP            | HCO Affiliation / Practice Location | Publications | Clinical Trials | Payments |
| :- | :------------- | :---------------------------------- | :----------- | :-------------- | :------- |
| 1 | MARIUS STAN    | MAYO CLINIC HOSPITAL ROCHESTER      | 57           | 7               | 18       |
| 2 | REBECCA BAHN   | MAYO CLINIC HOSPITAL ROCHESTER      | 35           | 2               | 15       |
| 3 | TERRY DAVIES   | MOUNT SINAI HOSPITAL                | 60           | 0               | 17       |
| 4 | YARON TOMER    | MOUNT SINAI HOSPITAL                | 35           | 1               | 0        |
| 5 | DAVID COOPER   | JOHNS HOPKINS HOSPITAL, THE         | 0            | 0               | 0        |
| 6 | NIDHI JAIN     | 701 NORTH UNIVERSITY AVENUE, LITTLE ROCK, | 0            | 0               | 484      |

## Slide 9: DocNexus Use Cases
Analyzing DocNexus' Ecosystem provides a comprehensive view of product, competitive, and centers of excellence

*   **Product Mapping**
    *   Assessing healthcare providers' utilization and preferences regarding specific treatments or therapies
    *   Understanding their prescribing habits and preferences can help tailor educational materials, support programs, and promotional activities accordingly
*   **Competitive Mapping**
    *   Identifying healthcare providers with collaborations or affiliations with relevant life science firms across research, development, or commercialization
    *   Partnering with these providers can facilitate access to resources, expertise, and potential joint initiatives
*   **HCP Identification & Influence Mapping**
    *   Mapping influential healthcare providers within specific institutions or medical centers
    *   Understanding the KOLs for new indications, differentiating between community, academic, and digital KOLs, and utilizing influence maps to assess their reach
    *   Building Advisory Boards or identifying PIs for Trials

## Slide 10: MARKET SIZE
With a 28% CAGR, the life science ecosystem and investment in digital solutions continues to grow exponentially

*   **28% YoY growth**
*   **TAM:** $40B
*   **SAM:** $22B
*   **SOM:** $5.5B

**Regional Breakdown (as indicated by map pins):**

*   **North America**
    *   484 Pharmaceutical Org
    *   971 Medical Device Firms
    *   450 Biotech Firms
    *   55K Medical Affairs Professionals
*   **South America**
    *   350 Total Pharmaceutical Org
    *   2K Medical Device Firms
    *   3K Biotech Firms
    *   15K Medical Affairs Professionals
*   **Europe**
    *   650 Total Pharmaceutical Org
    *   3K Medical Device Firms
    *   12K Biotech Firms
    *   45K Medical Affairs Professionals
*   **Asia**
    *   420 Total Pharmaceutical Org
    *   5K Medical Device Firms
    *   6K Biotech Firms
    *   25K Medical Affairs Professionals

## Slide 11: COMPETITIVE LANDSCAPE
DocNexus separates itself through high quality HCP search and its data depth for Medical & Commercial teams

**2x2 Matrix:**

*   **X-axis:** Low Quality HCP Search <---> High Quality HCP Search
*   **Y-axis:** Limited Data Depth for Medical & Commercial Teams <---> Significant Data Depth for Medical & Commercial Teams

|                     | Low Quality HCP Search                                  | High Quality HCP Search                               |
| :------------------ | :------------------------------------------------------ | :---------------------------------------------------- |
| **Significant Data Depth for Medical & Commercial Teams** | MSLInsight, Aissel, DOCDELTA, Within3, komodo HEALTH, H1. | doc nexus (in a dashed box, top right)                 |
| **Limited Data Depth for Medical & Commercial Teams**     | PHARMASPECTRA, Google Scholar, Veeva, ELSEVIER          | DEFINITIVE HEALTHCARE, IQVIA, AMiner                  |

## Slide 12: COMPETITIVE COMPARISON
DocNexus provides a full-suite of services relative to its competitors

| Feature                                                   | docnexus | Veeva | H1  | DEFINITIVE HEALTHCARE |
| :-------------------------------------------------------- | :------- | :---- | :-- | :-------------------- |
| Robust HCP Database                                       | ☑        | ☑     | ☑   | ☑                     |
| Multimedia Data Sources (YouTube, Podcasts, LinkedIn, Twitter) | ☑        | ☒     | ☒   | ☒                     |
| AI-Powered Influence Mappings for 7M+ HCPs                | ☑        | ☒     | ☒   | ☒                     |
| Semantic Search Engine & Ability to query by product, condition, or HCP | ☑        | ☒     | ☒   | ☒                     |
| Internal Data Ingestion & Comprehensive Claims Data       | ☑        | ☒     | ☒   | ☒                     |

**Legend:**
*   ☑: Full capability
*   ☒: No capability

## Slide 13: END USER AND END BUYER
DocNexus' Product improves the workflow for MSLs & Sales and results in cost savings for VPs of Medical Affairs / Commercial

|               | MSL / Commercial Teams                                                                                                   | Medical Affairs & Commercial VP                                                                                                                                                                                            |
| :------------ | :----------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Motivation**    | Spends more time communicating with KOLs rather than managing files and researching to keep up with therapeutic area trends | Wants her team to be more effective advocates for the medical devices that are coming to market; wants a better way to manage the workflow of her team                                                                           |
| **Current Solutions** | Company pays $30K/month for his team to use Pharma Spectra's Platform                                                    | Pays hundreds of thousands/year ($) for digital solutions for her MSL / Commercial teams to have most up-to-date information                                                                                                    |
| **Challenges**    | Dated platform with poor UX and old information, non-comprehensive, and non-real time feeds                                | Difficult to manage team and their output as they are using several platforms, resulting in low engagement for products coming to market                                                                                         |
| **Why DocNexus**  | DocNexus' HCP Search provides real-time reliable information about KOLs, synthesizes research trends and helps identify global experts based on search filters                                            | DocNexus' platform provides an end-to-end platform that enables her team to discover, identify, engage and manage KOLs. The robust pipeline helps to inform MA strategy and reach desired KPIs                                  |

## Slide 14: PRICING
Our pricing model offers flexibility to customers based on their needs

| Price Per TA (Therapy Area)                               | Price Per User                                                 | Price Per Geography | Price for Customer Success/Support                                                                                                                                                                                                                                                                      |
| :-------------------------------------------------------- | :------------------------------------------------------------- | :------------------ | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| $275K per TA (as outlined by your current TA segmentation in market) | Up to 15 Users are included                                    | Included for US     | *Included for all pricing tiers                                                                                                                                                                                                                                                                       |
| $225K each (2 TA)                                         | Additional Seats are: <br> $4K from 15-25 <br> $3K from 25-58 <br> $2K from 50-100 | $75K for all Geographies | Standard 10% for Customer Success.                                                                                                                                                                                                                                                                    |
| $175K each (3 TA)                                         |                                                                |                     | Enterprise Customers will have a dedicated Customer Success & Technical Account Manager that will meet monthly & discuss new features                                                                                                                                                                 |
| $150K each (4+ TA)                                        | *Unlimited Users Available                                     |                     |                                                                                                                                                                                                                                                                                                       |

## Slide 15: GTM STRATEGY
DocNexus is focused on 3 acquisition channels to drive growth

### Our primary acquisition channels

*   **CONFERENCES**
    *   MEDICAL AFFAIRS SPECIFIC
    *   COMMERCIAL SPECIFIC
    *   HEALTHCARE (HLTH, VIVE, JPM)
    *   THERAPEUTIC AREA SPECIFIC
*   **DIRECT OUTREACH**
    *   TARGETED OUTREACH
    *   EMAIL MARKETING
    *   PERSONAL NETWORK
    *   ADVISORS / MENTORS
    *   CONTENT MARKETING
*   **PARTNERSHIPS**
    *   CONSULTING FIRMS
    *   CHANNEL PARTNERS
    *   CRO'S

## Slide 16: MEET THE TEAM
Our team has expertise in healthcare, cloud computing, design, and engineering – enabling us to bridge the gap between Medical Affairs & Commercial and KOLs

**Team Members:**
*   **Mahek Chhatrapati**
    CEO/Co-Founder
    Engineer, MBA
*   **Andrei Assa**
    CTO/Co-Founder
    MD, MBA
*   **Gordon Silverman**
    COO/Co-Founder
    MPP, MBA

**ADVISORS:**
*   **David Goren**
    President
    AstraZeneca/Pfizer
*   **Junaid Bajwa**
    Chief Medical Scientist
    Microsoft
*   **Sanjit Misra**
    Epic/Iqvia

**Associated Logos (Companies of Advisors/Partners):**
*   Pfizer
*   Epic
*   AstraZeneca
*   NOVARTIS
*   IQVIA
*   Microsoft
*   aws

## Slide 17: TRACTION
We have seen growth across Fortune 50 pharma and medical device organizations and plan to expand our growth & customer base

**Monthly Revenue Bar Chart Data:**

| Month         | Revenue     |
| :------------ | :---------- |
| June-23       | $50,000     |
| July-23       | $50,000     |
| August-23     | $103,000    |
| September-23  | $248,000    |
| October-23    | $248,000    |
| November-23   | $998,000    |
| December-23   | $1,048,000  |

## Slide 18: MILESTONES FOR 2024
We have seen growth across Fortune 50 pharma and medical device organizations and plan to expand our growth & customer base

| DocNexus Metrics     | Jan 2023 – Jan 2024 | Jan 2024 - Jan 2025 |
| :------------------- | :------------------ | :------------------ |
| Run-Rate Total ARR   | $1.05M              | $6.7M               |
| Gross Margin (%)     | 88%                 | 90%                 |
| Gross Churn          | 0%                  | 0%                  |
| NRR                  | 100%                | 150%                |
| New Logo ARR (avg)   | $272,600            | $275,000            |

## Slide 19: HIGHLIGHTS & COMPANY NEWS
Our team's impressive credentials enable us to bridge the gap between Medical Affairs & Commercial and KOLs

*   Techstars Inaugural Class of Miami
*   TechCrunch Top 200 Startups
*   Top 1% for Mass Challenge
*   Creative Destruction Labs – Computational Health Seattle
*   Onboarded large Fortune 500 enterprise customers such as Johnson & Johnson and Roche Diagnostics
*   Joined the Washington Technology Industry Association Cohort
*   Joined the NVIDIA Inception Program and Data Bricks Startup

**Logos/Images:**
*   Johnson & Johnson
*   ACORAI
*   Roche
*   CHUGAI
*   techstars
*   STARTUP BATTLEFIELD 200 (PRESENTED BY CAPITAL CONNECT)
*   WTIA
*   NVIDIA. INCEPTION PROGRAM
*   Image of team members on "DUKE MAG" cover and in another professional setting.

## Slide 20: TRACTION & SUPPORT
Our team's impressive credentials and customers enable us to bridge the gap between Medical Affairs & Commercial and KOLs

**Customer/Partner Logos:**
*   Johnson & Johnson
*   Roche
*   CHUGAI
*   REGENXBIO™
*   ACORAI
*   EVERSANA
*   sanofi
*   amazon
*   Google
*   J.P.Morgan
*   MIT (Massachusetts Institute of Technology)
*   DUKE FUQUA (SCHOOL OF BUSINESS)
*   techstars
*   Stanford University logo
*   Duke University logo
*   STARTUP BATTLEFIELD 200 (PRESENTED BY CAPITAL CONNECT by JPMorgan)
*   aws
*   REDOX
*   Montefiore HEALTH SYSTEM
*   THE WHITE HOUSE WASHINGTON
*   THE LINDE GROUP
*   NOVARTIS
*   Epic
*   Multi-colored circle logo (similar to Google DeepMind or a generic analytics logo)
*   Deloitte.
*   Yale
*   WebMD
*   Harvard University shield
*   Pfizer
*   frog (design and strategy firm)

## Slide 21: FUNDRAISING
Raising a round of $3.5M for product development, salaries, operational cost, marketing, and sales

**Use of Funds (Pie Chart Data):**
*   **Personnel:** 47%
    Salaries and new hires (Engineering and Sales)
*   **Product Development:** 23%
    Claims Data Acquisition & Building HCP Network
*   **Marketing & Sales:** 19%
    Conferences, Webinars, Paid Ads, SEO and Partnerships
*   **Operational Costs:** 11%
    IT Services, Cloud Computing costs, legal, IP

## Slide 22: THANKS
(Image of three men, presumably the co-founders, wearing "techstars" hoodies, with arms crossed, smiling.)